Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351 - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Journal of Controlled Release Year : 2021

Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351

Fichier principal
Vignette du fichier
S0168365921004296.pdf (1.13 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03464861 , version 1 (16-10-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Mélanie Donnette, Mourad Hamimed, Joseph Ciccolini, Yael Berda-Haddad, Elise Kaspi, et al.. Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351. Journal of Controlled Release, 2021, 338, pp.244-252. ⟨10.1016/j.jconrel.2021.08.023⟩. ⟨hal-03464861⟩
68 View
2 Download

Altmetric

Share

Gmail Facebook X LinkedIn More